Tilray Brands, Inc.
General ticker "TLRY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $959.3M (TTM average)
Tilray Brands, Inc. does not follow the US Stock Market performance with the rate: -26.3%.
Estimated limits based on current volatility of 2.3%: low 3.99$, high 4.18$
Factors to consider:
- Total employees count: 3595 (+26.5%) as of 2026
- US accounted for 29.6% of revenue in the fiscal year ended 2024-05-31
- Top business risk factors: Regulatory and compliance, Agricultural crop failure, Security breaches, Market demand, Profitability
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-05-31 to 2028-05-30
- 2026-05-31 to 2027-05-31 estimated range: [2.85$, 7.01$]
- 2027-05-31 to 2028-05-30 estimated range: [2.65$, 6.46$]
Financial Metrics affecting the TLRY estimates:
- Positive: with PPE of -5.1 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Industry operating cash flow (median)
- Negative: 4.56 < Interest expense per share per price, % of 4.87
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term TLRY quotes
Long-term TLRY plot with estimates
Financial data
| YTD | 2024-05-31 | 2025-05-31 | 2026-05-31 |
|---|---|---|---|
| Operating Revenue | $788.94MM | $821.31MM | $915.45MM |
| Operating Expenses | $1,000.12MM | $3,104.01MM | $978.48MM |
| Operating Income | $-211.18MM | $-2,282.70MM | $-63.03MM |
| Non-Operating Income | $-37.84MM | $-19.67MM | $-25.03MM |
| Interest Expense | $67.13MM | $56.71MM | $29.91MM |
| R&D Expense | $0.87MM | $0.39MM | $0.36MM |
| Income(Loss) | $-249.02MM | $-2,302.37MM | $-88.06MM |
| Taxes | $-26.62MM | $-121.02MM | $17.10MM |
| Net Income(Loss)* | $-222.40MM | $-2,186.74MM | $-122.57MM |
| Stockholders Equity | $3,442.91MM | $1,511.47MM | $1,614.33MM |
| Inventory | $343.49MM | $371.70MM | $301.19MM |
| Assets | $4,221.66MM | $2,074.33MM | $2,328.01MM |
| Operating Cash Flow | $-30.91MM | $-94.60MM | $-69.14MM |
| Capital expenditure | $39.85MM | $45.17MM | $32.99MM |
| Investing Cash Flow | $128.35MM | $-46.72MM | $-55.80MM |
| Financing Cash Flow | $-75.19MM | $133.51MM | $130.99MM |
| Earnings Per Share** | $-2.99 | $-24.56 | $-1.10 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.